JO1930B1 - Presentation of bioactives - Google Patents

Presentation of bioactives

Info

Publication number
JO1930B1
JO1930B1 JO19961930A JOP19961930A JO1930B1 JO 1930 B1 JO1930 B1 JO 1930B1 JO 19961930 A JO19961930 A JO 19961930A JO P19961930 A JOP19961930 A JO P19961930A JO 1930 B1 JO1930 B1 JO 1930B1
Authority
JO
Jordan
Prior art keywords
acyl
alcohol group
fatty alcohol
bioactives
presentation
Prior art date
Application number
JO19961930A
Other languages
Arabic (ar)
Inventor
فريدريك هوروبين ديفيد
مانكو ميهار
ريدين بيتر
Original Assignee
سكوتيا هولدينجز بي ال سي
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by سكوتيا هولدينجز بي ال سي filed Critical سكوتيا هولدينجز بي ال سي
Application granted granted Critical
Publication of JO1930B1 publication Critical patent/JO1930B1/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Compounds of the following 1,3-propane diol linked structure, when for use in therapy: where R1 is an acyl or fatty alcohol group derived from a C12-30 preferably C¬16- 30 fatty acid desirably with two or more cis or trans double bonds, and R2 is hydrogen, or acyl or fatty alcohol group as R1 the same or different, or any other nutrient, drug or other bioactive residue
JO19961930A 1995-05-01 1996-05-02 Presentation of bioactives JO1930B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9508823.3A GB9508823D0 (en) 1995-05-01 1995-05-01 Drug Derivatives

Publications (1)

Publication Number Publication Date
JO1930B1 true JO1930B1 (en) 1997-01-15

Family

ID=10773801

Family Applications (1)

Application Number Title Priority Date Filing Date
JO19961930A JO1930B1 (en) 1995-05-01 1996-05-02 Presentation of bioactives

Country Status (5)

Country Link
CN (1) CN100391930C (en)
GB (1) GB9508823D0 (en)
JO (1) JO1930B1 (en)
UA (1) UA61884C2 (en)
ZA (3) ZA963360B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994392A (en) 1988-02-26 1999-11-30 Neuromedica, Inc. Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid
EP0914116B1 (en) * 1996-05-22 2000-10-11 Protarga Inc. Compositions comprising conjugates of cis-docosahexaenoic acid and taxotere
US5919815A (en) * 1996-05-22 1999-07-06 Neuromedica, Inc. Taxane compounds and compositions
US7015249B1 (en) 1997-12-12 2006-03-21 Purdue Research Foundation Methods and compositions for treating diabetes
CA2313626A1 (en) * 1997-12-12 1999-06-17 Purdue Research Foundation Methods and compositions for treating diabetes
US6225444B1 (en) 1998-02-10 2001-05-01 Protarga, Inc. Neuroprotective peptides and uses thereof
US6794375B2 (en) * 2000-01-28 2004-09-21 The Procter & Gamble Co. Palatable arginine compounds and uses thereof for cardiovascular health
US8288369B2 (en) * 2006-06-27 2012-10-16 University Of South Florida Delta-tocotrienol treatment and prevention of pancreatic cancer
CN102260177A (en) * 2010-05-25 2011-11-30 中国医学科学院药物研究所 Propylene glycol derivative, preparation method thereof, pharmaceutical composition thereof and application thereof
CN102260178A (en) * 2010-05-25 2011-11-30 中国医学科学院药物研究所 Hydroxyl propanediol derivative, its preparation method, its pharmaceutical composition and its purpose
BR112014027204A2 (en) * 2012-05-01 2017-06-27 Catabasis Pharmaceuticals Inc statin fatty acid conjugates and fxr agonists; compositions and method of uses
CN106957307B (en) * 2017-03-27 2019-06-28 淮阴工学院 A kind of dantrolene sodium derivative and preparation method thereof

Also Published As

Publication number Publication date
ZA963397B (en) 1996-08-07
GB9508823D0 (en) 1995-06-21
CN100391930C (en) 2008-06-04
UA61884C2 (en) 2003-12-15
ZA963360B (en) 1996-08-20
CN1189148A (en) 1998-07-29
ZA963433B (en) 1996-08-07

Similar Documents

Publication Publication Date Title
MY118354A (en) 1,3-propane diol derivatives as bioactive compounds
JO1930B1 (en) Presentation of bioactives
MY110765A (en) Compositions containing cholesteryl esters of unsaturated fatty acids
AU639323B2 (en) Cosmetic composition
CA2139771A1 (en) A cosmetic fatty acid triglyceride composition
CA2202338A1 (en) Skin care compositions containing fatty acid amides, azoles and retinol or retinyl ester
CA2175547A1 (en) Skin care compositions containing fatty acid amides and retinol or retinyl ester
CA2072027A1 (en) Cosmetic Compositions
SG43037A1 (en) New esters of bi-and tricyclic aminoalcohols their preparation and their use in pharmaceutical compositions
PT774962E (en) USING DHA AS A PHARMACEUTICAL COMPOSITION
CA2178105A1 (en) Skin care compositions containing dimethyl imidazolidinone and retinol or retinyl ester
CA2195419A1 (en) Immunological activity of rhamnolipids
IT1263013B (en) ESTERS OF L-CARNITINE AND ALCANOYL L-CARNITINE WITH GLYCOLIC ACID OR ITS ESTERS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH AS FOR THE TREATMENT OF SKIN DISEASES.
ES2014060A6 (en) Pharmaceutical compositions acting on the heart and cardiovascular system
CA2067365A1 (en) Illudin analogs as anti-tumor agents
CA2202339A1 (en) Skin care compositions containing melinamide and a retinoid
BG104470A (en) The use of a mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases
MY118589A (en) Cosmetic formulations useful in the prevention and therapy of hair loss and the use thereof
NZ237513A (en) Retinoic acid esters, preparation and pharmaceutical/cosmetic compositions thereof
CA2406783A1 (en) Skin whiteners containing hydroxytetronic acid
EP0719541A4 (en) Skin activator having glycosaminoglycan production accelerator activity
AU3206293A (en) A process for decoloring a fatty acid ester and a food or cosmetic composition containing the ester
CA2166468A1 (en) Cleansing Compositions Containing an Alkanoate as Conditioner
EP0681825A3 (en) Ferulic acid ester antioxidant/UV absorbent
MX9708386A (en) 1,3-propane diol derivatives as bioactive compounds.